Invention Grant
- Patent Title: Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
-
Application No.: US17216540Application Date: 2021-03-29
-
Publication No.: US11253494B2Publication Date: 2022-02-22
- Inventor: Mark Eller
- Applicant: Jazz Pharmaceuticals Ireland Limited
- Applicant Address: IE Dublin
- Assignee: Jazz Pharmaceuticals Ireland Limited
- Current Assignee: Jazz Pharmaceuticals Ireland Limited
- Current Assignee Address: IE Dublin
- Agency: Jones Day
- Main IPC: A61K31/19
- IPC: A61K31/19 ; A61K31/20 ; A61P11/00 ; A61P25/20 ; A61P43/00 ; A61K31/616 ; A61K31/33 ; A61K31/505 ; A61K31/55

Abstract:
One embodiment of the present invention is to improve the safety and efficacy of the administration of GHB or a salt thereof to a patient. It has been discovered that the concomitant administration of an MCT inhibitor, such as diclofenac, valproate, or ibuprofen, will affect GHB administration. For example, it has been discovered that diclofenac lowers the effect of GHB in the body, thereby potentially causing an unsafe condition. Furthermore, it has been discovered that valproate increases the effect of GHB on the body, thereby potentially causing an unsafe condition.
Public/Granted literature
- US20210212970A1 METHOD OF ADMINISTRATION OF GAMMA HYDROXYBUTYRATE WITH MONOCARBOXYLATE TRANSPORTERS Public/Granted day:2021-07-15
Information query